Human Genetics

, Volume 50, Issue 2, pp 107–143 | Cite as

Biochemistry and Genetics of gangliosidoses

  • K. Sandhoff
  • Helene Christomanou
Review Articles


The gangliosidoses comprise an-ever increasing number of biochemically and phenotypically variant diseases. In most of them an autosomal recessive inherited deficiency of a lysosomal hydrolase results in the fatal accumulation of glycolipids (predominantly in the nervous tissue) and of oligosaccharides.

The structure, substrate specificity, immunological properties of and genetic studies on the relevant glycosidases, ganglioside GM1 β-galactosidase and β-hexosaminidase isoenzymes, are reviewed in this paper. Contrary to general expectation, only a poor correlation is observed between the severity of the disease and residual activity of the defective enzyme when measured with synthetic or natural substrates in the presence of detergents. For the understanding of variant diseases and for their pre- and postnatal diagnosis, the necessity of studying the substrate specificity of normal and mutated enzymes under conditions similar to the in vivo situation, e.g., with natural substrates in the presence of appropriate activator proteins, is stressed. The possibility that detergents may have adverse affects on the substrate specificity of the enzymes is discussed for the β-hexosaminidases. The significance of activator proteins for the proper interaction of lipid substrates and watersoluble hydrolases is illustrated by the fatal glycolipid storage resulting from an activator protein deficiency in the AB variant of GM2-gangliosidosis. Recent somatic complementation studies have revealed the existence of a presumably post-translational modification factor necessary for the expression of ganglioside GM1 β-galactosidase activity. This factor is deficient in a group of variants of GM1-gangliosidosis. Among the possible reasons for the variability of enzyme activity levels in heterozygotes and patients, allelic mutations, formation of hybrid enzymes, and the existence of patients as compound heterozygotes are discussed. All these may result in the production of mutant enzymes with an altered specificity for a variety of natural substrates.


Oligosaccharide Substrate Specificity Natural Substrate Mutant Enzyme Compound Heterozygote 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



















N-acetylneuraminic acid




Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adachi, M., Schneck, L., Volk, B. W.: Progress in investigations of sphingolipidoses. Acta Neuropathol. (Berl.) 43, 1–18 (1978)Google Scholar
  2. Andermann, E., Andermann, F., Carpenter, S., Karpati, G., Grimes, D., Wolfe, L. S.: Juvenile Tay-Sachs disease (late-onset GM2-gangliosidosis) in two Lebanese families. Clin. Res. 22, 738A (1974)Google Scholar
  3. Andria, G., DelGiulice, C., Reuser, A. J. J.: Atypical expression of β-galactosidase deficiency in a child with Hurler-like features but without neurological abnormalities. Clin. Genet. 14, 16–23 (1978)PubMedGoogle Scholar
  4. Atsumi, T., Miyatake, T., Ohbuyashi, T., Mizuno, Y., Yoshida, M.: A case of Ramsey-Hunt syndrome with membranous cytoplasmatic bodies-like structures and β-galactosidase deficiency. Proc. Annu. Meet. Jpn. Neurol. Soc. (1976)Google Scholar
  5. Azzo, A. d', Hoogeveen, A., De Wit-Verbeek, H. A.: A rapid and simple microfractionation method for the analysis of hexosaminidase A and B activities in small numbers of cultured (amniotic fluid) cells. Clin. Chim. Acta 88, 1–7 (1978)CrossRefPubMedGoogle Scholar
  6. Bach, G., Suzuki, K.: Heterogeneity of human hepatic N-acetyl-β-d-hexosaminidase A activity toward natural glycosphingolipid substrates. J. Biol. Chem. 250, 1328–1332 (1975)PubMedGoogle Scholar
  7. Baecque, C. M. de, Suzuki, K., Rapin, I., Johnson, A. B., Whethers, D. L., Suzuki, K.: GM2-gangliosidosis, AB variant. Clinico-pathological study of a case. Acta Neuropathol. (Berl.) 33, 207–226 (1975)Google Scholar
  8. Baker, H. J., Lindsey, J. R.: Animal model of human disease: Feline GM1-gangliosidosis. Am. J. Pathol. 74, 649–652 (1974)PubMedGoogle Scholar
  9. Baker, H. J., Jr., Lindsey, J. R., McKhann, G. M., Farrell, D. F.: Neuronal GM1-gangliosidosis in a Siamese cat with β-galactosidase deficiency. Science 174, 838–839 (1971)PubMedGoogle Scholar
  10. Baker, H. J., Mole, J. A., Lindsey, J. R., Creel, R. M.: Animal models of human ganglioside storage diseases. Fed. Proc. 35, 1199–1201 (1976)Google Scholar
  11. Bartholomew, W. R., Rattazzi, M. C.: Immunochemical characterization of human β-d-N-acetyl-hexosaminidase from normal individuals and patients with Tay-Sachs disease. Int. Arch. Allergy Appl. Immunol. 46, 512–524 (1974)PubMedGoogle Scholar
  12. Bearpark, T., Stirling, J. L.: Clearance of human N-acetyl-β-hexosaminidases from rat circulation. Biochem. J. 168, 435–439 (1977)PubMedGoogle Scholar
  13. Bearpark, T. M., Stirling, J. L.: A difference in the specificities of human liver N-acetyl-β-hexosaminidases A and B, detected by their activities towards glycosaminoglycan oligosaccharides. Biochem. J. 173, 997–1000 (1978)PubMedGoogle Scholar
  14. Bearpark, T., Bouquelet, S., Fournet, B., Montreuil, J., Spik, G., Stirling, J., Strecker, G.: Activity of N-acetyl-β-d-hexosaminidases A and B from human liver towards various oligosaccharides and a glycopeptide core derived from glycoproteins. FEBS Lett. 84, 379–384 (1977)CrossRefPubMedGoogle Scholar
  15. Belfiore, F., Vecchio, L. L., Napoli, E., Borzi, V.: Increased β-N-acetylglucosaminidase activity in diabetes mellitus. Clin. Chem. 20, 1229–1230 (1974)PubMedGoogle Scholar
  16. Ben-Yoseph, Y., Geiger, B., Arnon, R.: Antibody-mediated thermal stabilization of human hexosaminidases. Immunochemistry 12, 221–226 (1975)CrossRefPubMedGoogle Scholar
  17. Ben-Yoseph, Y., Shapira, E., Edelman, D., Burton, B. K., Nadler, H. L.: Purification and properties of neutral β-galactosidases from human liver. Arch. Biochem. Biophys. 184, 373–379 (1977)PubMedGoogle Scholar
  18. Bernheimer, H.: Ganglioside im Liquor cerebrospinalis und Tay-Sachs'sche Erkrankung. Klin. Wochenschr. 46, 258–261 (1968)PubMedGoogle Scholar
  19. Bernheimer, H., Karbe, E.: Morphologische und neurochemische Untersuchungen von 2 Formen der amaurotischen Idiotie des Hundes: Nachweis einer GM2-Gangliosidose. Acta Neuropathol. (Berl.) 16, 243–261 (1970)Google Scholar
  20. Bernheimer, H., Seitelberger, F.: Über das Verhalten der Ganglioside im Gehirn bei 2 Fällen von spätinfantiler amaurotischer Idiotie. Wien. Klin. Wochenschr. 80, 163–164 (1968)PubMedGoogle Scholar
  21. Bernheimer, H., Molzer, B., Deisenhammer, E.: Sandhoff disease: ganglioside GM2 and asialo-GM2 accumulation in the cerebrospinal fluid. J. Neurochem. 29, 351–353 (1977)PubMedGoogle Scholar
  22. Berra, B., Brunngraber, E. G.: Neuropathological changes in brain glycoproteins. Biochem. Exp. Biol. 13, 31–40 (1977)PubMedGoogle Scholar
  23. Beutler, E., Kuhl, W.: Subunit structure of human hexosaminidase verified:interconvertibility of hexosaminidase isozymes. Nature 258, 262–264 (1975)PubMedGoogle Scholar
  24. Beutler, E., Kuhl, W., Comings, D.: Hexosaminidase isoenzyme in type 0 GM2-gangliosidosis (Sandhoff-Jatzkewitz disease). Am. J. Hum. Genet. 27, 628–638 (1975a)PubMedGoogle Scholar
  25. Beutler, E., Villacorte, D., Kuhl, W., Guinto, E., Srivastava, S.: Nonenzymatic conversion of human hexosaminidase A. J. Lab. Clin. Med. 86, 195–203 (1975b)PubMedGoogle Scholar
  26. Beutler, E., Yoshida, A., Kuhl, W., Lee, J. E. S.: The subunits of human hexosaminidase A. Biochem. J. 159, 541–543 (1976)PubMedGoogle Scholar
  27. Blakemore, W. F.: GM1-gangliosidosis in a cat. J. Comp. Pathol. 82, 179–185 (1972)CrossRefPubMedGoogle Scholar
  28. Booth, C. W., Gerbie, A. B., Nadler, H. L.: Intrauterine detection of GM1 gangliosidosis, type 2. Pediatrics 52, 521–524 (1973)PubMedGoogle Scholar
  29. Bootsma, D., Galjaard, H.: Heterogeneity in genetic diseases studied in cultured cells. In: Models for the study of inborn errors of metabolism, F. A. Hommes (ed.). Amsterdam: Excerpta Medica (in press, 1979)Google Scholar
  30. Brady, R. O.: Sphingolipidoses. Annu. Rev. Biochem. 47, 687–713 (1978)CrossRefPubMedGoogle Scholar
  31. Brady, R. O., Pentchev, P. G., Gal, A. E.: Investigations in enzyme replacement therapy in lipid storage diseases. Fed. Proc. 34, 1310–1315 (1975)PubMedGoogle Scholar
  32. Braidman, I., Carroll, M., Dance, N., Robinson, D., Poenaru, L., Weber, A., Dreyfus, J. C., Overdijk, B., Hooghwinkel, G. J. M.: Characterisation of human N-acetyl-β-hexosaminidase C. FEBS Lett. 41, 181–184 (1974a)CrossRefPubMedGoogle Scholar
  33. Braidman, I., Carroll, M., Dance, N., Robinson, D.: Separation and properties of human brain hexosaminidase C. Biochem. J. 143, 295–301 (1974b)PubMedGoogle Scholar
  34. Brandt, S., Clausen, J., Diemer, N. H., Faurholt-Pedersen, V., Jensen, G. E., Lademann, A., Melchior, J. C.: Juvenile neurolipidosis of Bernheimer-Seitelberger's type. Acta Neurol. Scand. 56, 587–602 (1977)PubMedGoogle Scholar
  35. Brett, E. M., Ellis, R. B., Haas, L., Ikonne, J. U., Lake, B. D., Patrick, A. D., Stephens, R.: Lateonset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on eight patients. Arch. Dis. Child. 48, 775–785 (1973)PubMedGoogle Scholar
  36. Brunngraber, E. G., Witting, L. A., Haberland, C., Brown, B.: Glycoproteins in Tay-Sachs disease: Isolation and carbohydrate composition of glycopeptides. Brain Res. 38, 151–162 (1972)CrossRefPubMedGoogle Scholar
  37. Brunngraber, E. G., Brown, B. D., Aro, A.: Glycoproteins in brain tissue of 0-variant of GM2-gangliosidosis. J. Neurochem. 22, 125–128 (1974)PubMedGoogle Scholar
  38. Burton, B. K., Ben-Yoseph, Y., Nadler, H. L.: Lactosyl ceramidosis: deficient activity of neutral β-galactosidase in liver and cultivated fibroblasts? Clin. Chim. Acta 88, 483–493 (1978)CrossRefPubMedGoogle Scholar
  39. Buxton, P., Cumings, J. N., Ellis, R. B., Lake, B. D., Mair, W. G. P., Roberts, J. R., Young, E. P.: A case of GM2-gangliosidosis of late onset. J. Neurol. Neurosurg. Psychiatry 35, 685–692 (1972)PubMedGoogle Scholar
  40. Cantz, M., Kresse, H.: Sandhoff disease: Defective glycosaminoglycan catabolism in cultured fibroblasts and its correction by β-N-acetylhexosaminidase. Eur. J. Biochem. 47, 581–590 (1974)PubMedGoogle Scholar
  41. Carmody, P. J., Rattazzi, M. C.: Conversion of human hexosaminidase A to hexosaminidase ‘B’ by crude Vibrio cholerae neuraminidase preparations: Merthiolate is the active factor. Biochim. Biophys. Acta 371, 117–125 (1974)Google Scholar
  42. Carroll, M.: Characterization of proteins structurally related to human N-acetyl-β-d-glucosaminidase. Biochem. J. 173, 191–196 (1978)PubMedGoogle Scholar
  43. Carroll, M., Robinson, D.: Immunological properties of N-acetyl-β-d-glucosaminidase of normal human liver and of GM2-gangliosidosis liver. Biochem. J. 131, 91–96 (1973)PubMedGoogle Scholar
  44. Carroll, M., Robinson, D.: A low-molecular-weight protein cross-reacting with human liver N-acetyl-β-d-glucosaminidase. Biochem. J. 137, 217–221 (1974)PubMedGoogle Scholar
  45. Cheetham, P. S. J., Robinson, D., Blakemore, W. F.: Animal models for GM1-gangliosidosis. Biochem. Soc. Trans. 2, 1121–1124 (1974)Google Scholar
  46. Cheetham, P. S. J., Dance, N. E., Robinson, D.: A benign deficiency of type B β-galactosidase in human liver. Clin. Chim. Acta 83, 67–74 (1978)CrossRefPubMedGoogle Scholar
  47. Chern, C. J., Beutler, E., Kuhl, W., Gilbert, F., Mellman, W. J., Croce, C. M.: Characterization of heteropolymeric hexosaminidase A in human x mouse hybrid cells. Proc. Natl. Acad. Sci. USA 73, 3637–3640 (1976)PubMedGoogle Scholar
  48. Chern, C. J., Kennett, R., Engel, E., Mellman, W. J., Croce, C. M.: Assignment of the structural genes for the α subunit of hexosaminidase A, mannosephosphate isomerase, and pyruvate kinase to the region q22-qter of human chromosome 15. Somatic Cell Genetics 3, 553–560 (1977)PubMedGoogle Scholar
  49. Christomanou, H., Cáp, C., Sandhoff, K.: Prenatal diagnosis of Tay-Sachs disease in cell-free amniotic fluid. Klin. Wochenschr. 56, 1133–1135 (1978)PubMedGoogle Scholar
  50. Cohen, C. M., Weissmann, G., Hoffstein, S., Awasthi, Y. C., Srivastava, S. K.: Introduction of purified hexosaminidase A into Tay-Sachs leukocytes by means of immunoglobulin-coated liposomes. Biochemistry 15, 452–460 (1976)PubMedGoogle Scholar
  51. Conzelmann, E., Sandhoff, K.: AB variant of infantile GM2-gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Proc. Natl. Acad. Sci. USA 75, 3979–3983 (1978)PubMedGoogle Scholar
  52. Conzelmann, E., Sandhoff, K., Nehrkorn, H., Geiger, B., Arnon, R.: Purification, biochemical and immunological characterisation of hexosaminidase A from variant AB of infantile GM2 gangliosidosis. Eur. J. Biochem. 84, 27–33 (1978)PubMedGoogle Scholar
  53. Cork, L. C., Munnell, J. F., Lorenz, M. D., Murphy, J. V., Baker, H. J., Rattazzi, M. C.: GM2-ganglioside lysosomal storage disease in cats with β-hexosaminidase deficiency. Science 196, 1014–1017 (1977)PubMedGoogle Scholar
  54. Cork, L. C., Munnell, J. F., Lorenz, M. D.: The pathology of feline GM2-gangliosidosis. Am. J. Pathol. 90, 723–734 (1978)PubMedGoogle Scholar
  55. Desnick, R. J., Simmons, R. L., Allen, K. Y., Woods, J. E., Anderson, C. F., Najarian, J. S., Krivit, W.: Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery 72, 203–211 (1972)PubMedGoogle Scholar
  56. Desnick, R. J., Krivit, W., Sharp, H. L.: In utero diagnosis of Sandhoff's disease. Biochem. Biophys. Res. Commun. 51, 20–26 (1973a)PubMedGoogle Scholar
  57. Desnick, S. J., Desnick, R. J., Brady, R. O., Pentchev, P. G., Simmons, R. L., Najarian, J. S., Swaiman, K., Sharp, H. L., Krivit, W.: Renal transplantation in type II Gaucher disease. Birth Defects 9, 109–119 (1973b)PubMedGoogle Scholar
  58. Desnick, R. J., Thorpe, S. R., Fiddler, M. B.: Toward enzyme therapy for lysosomal storage diseases. Physiol. Rev. 56, 57–99 (1976)PubMedGoogle Scholar
  59. Donnelly, W. J. C., Sheahan, B. J., Kelly, M.: Beta-galactosidase deficiency in GM1-gangliosidosis of Friesian calves. Res. Vet. Sci. 15, 139–141 (1973)PubMedGoogle Scholar
  60. Dreyfus, J. C., Poenaru, L., Svennerholm, L.: Absence of hexosaminidase A and B in a normal adult. N. Engl. J. Med. 292, 61–63 (1975)PubMedGoogle Scholar
  61. Dreyfus, J. C., Poenaru, L., Vibert, M., Ravise, N., Boue, J.: Characterization of a variant of β-hexosaminidase: ‘Hexosaminidase Paris’. Am. J. Hum. Genet. 29, 287–293 (1977)PubMedGoogle Scholar
  62. Farrell, D. F., Baker, H. J., Herndon, R. M., Lindsey, J. R., McKhann, G. M.: Feline GM1-gangliosidosis: Biochemical and ultrastructural comparisons with the disease in man. J. Neuropathol. Exp. Neurol. 32, 1–18 (1973)PubMedGoogle Scholar
  63. Felding, J., Hultberg, B.: An atypical form of Sandhoff's disease. Case report and biochemical studies. Neuropaediatrie 9, 74–83 (1978)Google Scholar
  64. Fiddler, M. B., Thorpe, S. R., Desnick, R. J.: Enzyme therapy: in vivo administration of erythrocyte-entrapped β-glucuronidase. Am. J. Hum. Genet. 26, 30A (1974)Google Scholar
  65. Figura, K. von: Secretion of β-hexosaminidase by cultured human skin fibroblasts. Kinetics, effect of temperature, cell density, serum concentration and pH. Exp. Cell Res. 111, 15–21 (1978)PubMedGoogle Scholar
  66. Fischer, G., Jatzkewitz, H.: The activator of cerebroside sulphatase. Binding studies with enzyme and substrate demonstrating the detergent function of the activator protein. Biochim. Biophys. Acta 481, 561–572 (1977)PubMedGoogle Scholar
  67. Fischer, G., Jatzkewitz, H.: The activator of cerebroside sulphatase. A model of the activation. Biochim. Biophys. Acta 528, 69–76 (1978)PubMedGoogle Scholar
  68. Fluharty, A. L., Stevens, R. L., Kihara, H.: Cerebroside sulfate hydrolysis by fibroblasts from a parent with metachromatic leukodystrophy. J. Pediatr. 92, 782–784 (1978)PubMedGoogle Scholar
  69. Friedland, J., Schneck, L., Saifer, A., Pourfar, M., Volk, B. W.: Identification of Tay-Sachs disease carriers by acrylamide gel electrophoresis. clin. Chim. Acta 28, 397–402 (1970)CrossRefPubMedGoogle Scholar
  70. Frost, R. G., Holmes, E. W., Norden, A. G. W., O'Brien, J. S.: Characterization of purified human liver acid β-d-galactosidasesA2 and A3. Biochem. J. 175, 181–188 (1978)PubMedGoogle Scholar
  71. Galjaard, H., Hoogeveen, A., De Wit-Verbeek, H. A., Reuser, A. J. J., Kiejzer, W., Westerveld, A., Bootsma, D.: Tay-Sachs and Sandhoff's disease: Intergenic complementation after somatic cell hybridization. Exp. Cell Res. 87, 444–448 (1974a)PubMedGoogle Scholar
  72. Galjaard, H., Reuser, A. J. J., Henkels-Dully, M. J., Hoogeveen, A., Keijzer, W., De Wit-Verbeek, H. A., Niermeijer, M. F.: Genetic heterogeneity and variation of lysosomal enzyme activities in cultured human cells. In: Enzyme therapy in lysosomal storage diseases, J. M. Tager, G. J. M. Hooghwinkel, W. T. Daems (eds.), pp. 35–51. Amsterdam: North-Holland (1974b)Google Scholar
  73. Galjaard, H., Hoogeveen, A., Keijzer, W., De Wit-Verbeek, H. A., Reuser, A. J. J., Ho, W. M., Robinson, D.: Genetic heterogeneity in GM1-gangliosidosis. Nature 257, 60–62 (1975)PubMedGoogle Scholar
  74. Galjaard, H., Hoogeveen, A., Van Der Veer, E., Kleyer, W. J.: Microtechniques in prenatal diagnosis of genetic disease: Present scope and future possibilities. In: Proceedings of the Fifth International Congress of Human Genetics (Mexico City, 1976). Amsterdam: Excerta Medica 1977Google Scholar
  75. Gatt, S., Barenholz, Y.: Enzymes of complex lipid metabolim. Annu. Rev. Biochem. 42, 61–90 (1973)CrossRefPubMedGoogle Scholar
  76. Geiger, B., Arnon, R.: Chemical characterization and subunit structure of human N-acetyl-hexosaminidases A and B. Biochemistry 15, 3484–3492 (1976)PubMedGoogle Scholar
  77. Geiger, B., Ben-Yoseph, Y., Arnon, R.: Purification of human hexosaminidases A and B by affinity chromatography. FEBS Lett. 45, 276–281 (1974)CrossRefPubMedGoogle Scholar
  78. Geiger, B., Navon, R., Ben-Yoseph, Y., Arnon, R.: Specific determination of N-acetyl-β-d-hexosaminidase isozymes A and B by radioimmunoassay and radial immunodiffusion. Eur. J. Biochem. 56, 311–318 (1975)PubMedGoogle Scholar
  79. Geiger, B., Arnon, R., Sandhoff, K.: Immunochemical and biochemical investigation of hexosaminidase S. Am. J. Hum. Genet. 29, 508–522 (1977a)PubMedGoogle Scholar
  80. Geiger, B., Specht, B. U. von, Arnon, R.: Stabilization of human β-d-N-acetylhexosaminidase A towards proteolytic inactivation by coupling it to poly-N-vinylpyrrolidone. Eur. J. Biochem. 73, 141–147 (1977b)PubMedGoogle Scholar
  81. Geiger, B., Calef, E., Arnon, R.: Biochemical and immunochemical characterization of hexosaminidase P. Biochemistry 17, 1713–1717 (1978a)PubMedGoogle Scholar
  82. Geiger, B., Navon, R., Arnon, R.: Hexosaminidase A in amniotic fluid of Tay-Sachs fetuses. Clin. Chem. 24, 1131–1133 (1978b)PubMedGoogle Scholar
  83. George, D. L., Francke, U.: Regional mapping of human genes for hexosaminidase B and diphtheria toxin sensitivity on chromosome 5 using mouse x human hybrid cells. Somatic Cell Genetics 3, 629–638 (1977)PubMedGoogle Scholar
  84. Gilbert, F., Kucherlapati, R., Creagan, R., Murnane, M. J., Darlington, G. J., Ruddle, F. H.: Tay-Sachs' and Sandhoff's disease: The assignment of genes for hexosaminidase A and B to individual human chromosomes. Proc. Natl. Acad. Sci. USA 72, 263–267 (1975).PubMedGoogle Scholar
  85. Goldberg, M. F., Cotlier, E., Fichenscher, L. G., Kenyon, K., Enat, R., Borowsky, S. A.: Macular cherry-red spot, corneal clouding, and β-galactosidase deficiency. Arch. Intern. Med. 128, 387–398 (1971)CrossRefPubMedGoogle Scholar
  86. Goldberg, J. D., Truex, J. H., Desnick, R. J.: Tay-Sachs disease: an improved, fully automated method for heterozygote identification by tear β-hexosaminidase assay. Clin. Chim. Acta 77, 43–52 (1977)CrossRefPubMedGoogle Scholar
  87. Goldie, W. D., Holtzman, D., Suzuki, K.: Chronic hexosaminidase A and B deficiency. Ann. Neurol. 2, 156–158 (1977)Google Scholar
  88. Gregoriadis, G.: Liposomes in biology and medicine. Nature 271, 112–113 (1978a)Google Scholar
  89. Gregoriadis, G.: Liposomes in therapy of lysosomal storage diseases. Nature 275, 695–698 (1978b)PubMedGoogle Scholar
  90. Halley, D. J. J., De, Wit-Verbeek, H. A., Reuser, A. J. J., Galjaard, H.: The distribution of hydrolytic enzyme activities in human fibroblast cultures and their intercellular transfer. Biochem. Biophys. Res. Commun. 82, 1176–1182 (1978)PubMedGoogle Scholar
  91. Handa, S., Yamakawa, T.: Biochemical studies in cat and human gangliosidosis. J. Neurochem. 18, 1275–1280 (1971)PubMedGoogle Scholar
  92. Hansson, H. A., Holmgren, J., Svennerholm, L.: Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc. Natl. Acad. Sci. USA 74, 3782–3786 (1977)PubMedGoogle Scholar
  93. Harzer, K.: Inheritance of the enzyme deficiency in three neurolipidoses: variant 0 of Tay-Sachs disease (Sandhoff's disease), classic Tay-Sachs disease, and metachromatic leukodystrophy. Identification of the heterozygous carriers. Humangenetik 20, 1–12 (1973)PubMedGoogle Scholar
  94. Harzer, K., Benz, H. U.: Gangliosidosen: In: Handbuch der inneren Medizin, Band VII/4: Fett-stoffwechsel, G. Schettler, H. Greten, D. Seidel (eds.), pp 613–643, Berlin-Heidelberg-New York: Springer 1976Google Scholar
  95. Harzer, K., Recke, A. S.: Sulfatide-excreting heterozygous carrier of juvenile metachromatic Leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy. Humangenetik 29, 299–307 (1975)PubMedGoogle Scholar
  96. Harzer, K., Sandhoff, K., Schall, H., Kollmann, F.: Enzymatische Untersuchungen in Blut von Überträgern einer Variante der Tay-Sachs'schen Erkrankung (Variante 0). Klin. Wochenschr. 49, 1189–1191 (1971)PubMedGoogle Scholar
  97. Hechtman, P.: Characterization of an activating factor required for hydrolysis of GM2 ganglioside catalyzed by hexosaminidase A. Can. J. Biochem. 55, 315–324 (1977)PubMedGoogle Scholar
  98. Hechtman, P., Le, Blanc, D.: Purification and properties of the hexosaminidase A-activating protein from human liver. Biochem. J. 167, 693–701 (1977)PubMedGoogle Scholar
  99. Hers, H. G., Van, Hoff, F.: Lysosomes and storage diseases. New York: Academic Press 1973Google Scholar
  100. Ho, M. W., O'Brien, J. S.: Stimulation of acid beta-galactosidase activity by chloride ions. Clin. Chim. Acta 30, 531–534 (1970)CrossRefPubMedGoogle Scholar
  101. Ho, M. W., O'Brien, J. S.: Gaucher's disease: deficiency of ‘acid’ β-glucosidase and reconstitution of enzyme activity in vitro. Proc. Natl. Acad. Sci. USA 68, 2810–2813 (1971)PubMedGoogle Scholar
  102. Ho, M. W., Cheetham, P., Robinson, D.: Hydrolysis of GM1-ganglioside by human liver β-galactosidase isoenzymes. Biochem. J. 136, 351–359 (1973)PubMedGoogle Scholar
  103. Ho, M. W., Norden, A. G. W., Alhadeff, J. A., O'Brien, J. S.: Glycosphingolipid hydrolases: properties and molecular genetics. Mol. Cell. Biochem. 17, 125–140 (1977)PubMedGoogle Scholar
  104. Hoeksema, H. L., Reuser, A. J. J., Hoogeveen, A. T., Westerveld, A., Galjaard, H.: Characterization of residual hexosaminidase activity in Sandhoff's disease using man-Chinese hamster cell hybrids. Hum. Genet. 39, 315–319 (1977a)PubMedGoogle Scholar
  105. Hoeksema, H. L., Reuser, A. J. J., Hoogeveen, A., Westerveld, A., Braidman, I., Robinson, D.: Characterization of β-d-N-acetylhexosaminidase isoenzymes in man-Chinese hamster somatic cell hybrids. Am. J. Hum. Genet. 29, 14–23 (1977b)PubMedGoogle Scholar
  106. Hoeksema, H. L., Van Diggelen, O. P., Galjaard, H.: Intergenic complementation after fusion of fibroblasts from different patients with β-galactosidase deficiency. Biochim. Biophys. Acta (in press), (1979)Google Scholar
  107. Holmes, E. W., O'Brien, J. S.: Feline GM1-gangliosidosis: Characterization of the residual liver acid β-galactosidase. Am. J. Hum. Genet. 30, 505–515 (1978)PubMedGoogle Scholar
  108. Hösli, P.: Quantitative assays of enzyme activity in single cells: early prenatal diagnosis of genetic disorders. Clin. Chem. 23, 1476–1484 (1977)PubMedGoogle Scholar
  109. Hooghwinkel, G. J. M., Veltkamp, W. A., Overdijk, B., Lisman, J. J. W.: Electrophoretic separation of β-N-acetylhexosaminidases of human and bovine brain and liver and of Tay-Sachs tissue. Hoppe Seylers Z. Physiol. Chem. 353, 839–841 (1972)PubMedGoogle Scholar
  110. Hultberg, B.: N-Acetylhexosaminidase activities in Tay-Sachs disease. Lancet 1969 II, 1195-1195Google Scholar
  111. Humbel, R., Collart, M.: Oligosaccharides in urine of patients with glycoprotein storage diseases. I. Rapid detection by thin layer chromatography. Clin. Chim. Acta 60, 143–145 (1975)CrossRefPubMedGoogle Scholar
  112. Ihler, G. M., Glew, R. H., Schnure, F. W.: Enzyme loading of erythrocytes. Proc. Natl. Acad. Sci. USA 70, 2663–2666 (1973)PubMedGoogle Scholar
  113. Ikonne, J. U., Rattazzi, M. C., Desnick, R. J.: Characterization of hex S, the major residual β hexosaminidase activity in type 0 GM2 gangliosidosis (Sandhoff-Jatzkewitz disease). Am. J. Hum. Genet. 27, 639–650 (1975)PubMedGoogle Scholar
  114. Iwamori, M., Nagai, Y.: Ganglioside-composition of brain in Tay-Sachs disease: Increased amounts of GD2 and N-acetyl-β-d-galactosaminyl GD1a ganglioside. Neurochem. R. 3, 670–671 (1978)Google Scholar
  115. Iwamori, M., Nagai, Y.: Ganglioside-composition of brain in Tay-Sachs disease: Increased amounts of GD2 and N-acetyl-β-d-galactosaminyl GD1a ganglioside. J. Neurochem. (in press, 1979)Google Scholar
  116. Jatzkewitz, H., Sandhoff, K.: On a biochemically special form of infantile amourotic idiocy. Biochim. Biophys. Acta 70, 354–356 (1963)CrossRefGoogle Scholar
  117. Jatzkewitz, H., Pilz, H., Sandhoff, K.: deQuantitative Bestimmungen von Gangliosiden und ihren neuraminsäurefreien Derivaten bei infantilen, juvenilen und adulten Formen der amaurotischen Idiotie und einer spätinfantilen biocheischen Sonderform. J. Neurochem. 12, 135–144 (1965)PubMedGoogle Scholar
  118. Johnson, W. G., Chutorian, A. M.: Inheritance of a new form of hexosaminidase deficiency. Ann. Neurol. 2, 266–266 (1977)Google Scholar
  119. Johnson, W. G., Chutorian, A. M.: Inheritance of the enzyme defect in a new hexosaminidase deficiency disease. Ann. Neurol. 4, 399–403 (1978)PubMedGoogle Scholar
  120. Johnson, W. G., Chutorian, A., Miranda, A.: A new juvenile hexosaminidase deficiency disease presenting as cerebellar ataxia. Neurology 27, 1012–1018 (1977)PubMedGoogle Scholar
  121. Jørgensen, L., Blacksted, T. W., Harkmark, W., Steen, J. A.: Niemann-Pick disease: report of a case with histochemical evidence of neural storage of acid glycolipids. Arch. Neuropathol. (Berl.) 4, 90–106 (1964)Google Scholar
  122. Kaback, M. M.: Tay-Sachs disease: screening and prevention. Prog. Clin. Biol. Res. 18, 0000–0000 (1977)Google Scholar
  123. Kaback, M. M., Zeiger, R. S.: Heterozygote detection in Tay-Sachs disease. A prototype community screening program for the prevention of recessive genetic disorders. Adv. Exp. Med. Biol. 19, 613–632 (1972)Google Scholar
  124. Kaback, M. M., Hirsch, P., Roy, C., Greenwald, S., Kirk, M.: Gene frequncies for Tay-Sachs (TSD) and Sandhoff's disease (SD) in Jewish and non-Jewish populations. Pediatr. Res. 12, 452–452 (1978)Google Scholar
  125. Kan, Y. W., Dozy, A. M.: Antenatal diagnosis of sickle-cell anaemia by DNA analysis of amniotic-fluid cells. Lancet 1978 II, 910–912Google Scholar
  126. Kaplan, A., Achord, D. T., Sly, W. S.: Phosphohexosyl components of a lysosomal enzyme are recognized by pinocytosis receptors on human fibroblasts. Proc. Natl. Acad. Sci. USA 74, 2026–2030 (1977)PubMedGoogle Scholar
  127. Kelly, T. E., Reynolds, L. W., O'Brien, J. S.: Segregation within a family of two mutant alleles for hexosaminidase A. Clin. Genet. 9, 540–543 (1976)PubMedGoogle Scholar
  128. Kihara, H., Porter, M. T., Fluharty, A. L.: Enzyme replacement in cultured fibroblasts from metachromatic leukodystrophy. Birth Defects 9, 19–26 (1973)Google Scholar
  129. Kleijer, W. J., Niermeijer, M. F., Galjaard, H.: Enzyme studies on small numbers of cultured cells. (in press, 1979)Google Scholar
  130. Klenk, E.: Beiträge zur Chemie der Lipidosen. I. Niemann-Pick'sche Krankheit und amaurotische Idiotie. Hoppe Seylers Z. Physiol. Chem. 262, 128–143 (1939/1940)Google Scholar
  131. Klenk, E.: Über die Ganglioside, eine neure Gruppe von zuckerhaltigen Gehirnlipoiden. Hoppe Seylers Z. Physiol. Chem. 273, 76–86 (1942)Google Scholar
  132. Kolodny, E. H.: Sandhoff's disease: studies on the enzyme defect in homozygotes and detection of heterozygotes. Adv. Exp. Med. Biol. 19, 321–341 (1972)Google Scholar
  133. Kolodny, E. H., Mumford, R. A.: Human leucocyte acid hydrolases: characterization of eleven lysosomal hydrolases and study of reaction conditions for their automated analysis. Clin. Chim. Acta 70, 247–257 (1976)CrossRefPubMedGoogle Scholar
  134. Koster, J. F., Niermeijer, M. F., Loonen, M. C. B., Galjaard, H.: β-Galactosidase deficiency in an adult: a biochemical and somatic cell genetic study on a variant of GM1-gangliosidosis. Clin. Genet. 9, 427–432 (1976)PubMedGoogle Scholar
  135. Krivit, W., Desnick, R. J., Lee, J., Moller, J., Wright, F., Sweeley, C. C., Snyder, P. D., Sharp, H. L.: Generalized accumulation of neutral glycosphingolipids with GM2 ganglioside accumulation in the brain. Am. J. Med. 52, 763–770 (1972)CrossRefPubMedGoogle Scholar
  136. Kudoh, T., Kikuchi, K., Nakamura, F., Yokoyama, S., Karube, K., Tsugawa, S., Minami, R., Nakao, T.: Prenatal diagnosis of GM1-gangliosidosis: biochemical manifestations in fetal tissues. Hum. Genet. 44, 287–293 (1978)PubMedGoogle Scholar
  137. Kuhn, R., Wiegandt, H.: Die Konstitution der Ganglio-N-tetraose und des Gangliosids G1. Chem. Ber. 96, 866–880 (1963)Google Scholar
  138. Lalley, P. A., Rattazzi, M. C., Shows, T. B.: Human β-d-N-acetylhexosaminidases A and B: expression and linkage relationships in somatic cell hybrids. Proc. Natl. Acad. Sci. USA 71, 1569–1573 (1974)PubMedGoogle Scholar
  139. Landa, C. A., Maccioni, H. J. F., Arce, A. Caputto, R.: The biosynthesis of brain gangliosides. Separation of membranes with different ratios of ganglioside-sialylating activity to gangliosides. Biochem. J. 168, 325–332 (1977)PubMedGoogle Scholar
  140. Lane, A. B., Jenkins, T.: Two variant hexosaminidase β-chain alleles segregating in a South African family. Clin. Chim. Acta 87, 219–228 (1978)CrossRefPubMedGoogle Scholar
  141. Ledeen, R. W.: Ganglioside structures and distribution: are they localized at the nerve ending? J. Supramol. Struct. 8, 1–17 (1978)PubMedGoogle Scholar
  142. Ledeen, R. W., Salsman, K.: Structure of the Tay-Sachs' ganglioside. I. Biochemistry 4, 2225–2233 (1965)Google Scholar
  143. Lee, J. E. S., Yoshida, A.: Purification and chemical characterization of human hexosaminidases A and B. Biochem. J. 159, 535–539 (1976)PubMedGoogle Scholar
  144. Li, S.-C., Li, Y.-T.: An activator stimulating the enzymic hydrolysis of sphingoglycolipids. J. Biol. Chem. 251, 1159–1163 (1976)PubMedGoogle Scholar
  145. Li, S. C., Wan, C. C., Mazzotta, M. Y., Li, Y. T.: Requirement of an activator for the hydrolysis of sphingoglycolipids by glycosidases of human liver. Carbohydr. Res. 34, 189–193 (1974)CrossRefPubMedGoogle Scholar
  146. Li, Y.-T., Mazzotta, M. Y., Wan, C.-C., Orth, R., Li, S.-C.: Hydrolysis of Tay-Sachs ganglioside by β-hexosaminidase A of human liver and urine. J. Biol. Chem. 248, 7512–7515 (1973)PubMedGoogle Scholar
  147. Lowden, J. A.: Evidence for a hybrid hexosaminidase isoenzyme in heterozygotes for Sandhoff disease. Am. J. Hum. Genet. (in press, 1979)Google Scholar
  148. Lowden, J. A., Callahan, J. W., Norman, M. G., Thain, M., Prichard, J. S.: Juvenile GM1-gangliosidosis. Arch. Neurol. 31, 200–203 (1974)PubMedGoogle Scholar
  149. Lowden, J. A., Burton, R. M., Desnick, R. J., Goodman, S., Kaback, M. M., Kolodny, E. H., Rattazzi, M. C., Saifer, A.: Tay-Sachs carrier screening: a manual of methods. National Tay-Sachs and Allied Disease Association 1976Google Scholar
  150. Lowden, J. A., Ives, E. J., Keene, D. L., Burton, A. L., Skomorowski, M. A., Howard, F.: Carrier detection in Sandhoff disease. Am. J. Hum. Genet. 30, 38–45 (1978)PubMedGoogle Scholar
  151. Lundblad, A., Sjöblad, S., Svensson, S.: Characterization of a penta-and an octasaccharide from urine of a patient with juvenile GM1-gangliosidosis. Arch. Biochem. Biophys. 188, 130–136 (1978)PubMedGoogle Scholar
  152. MacLeod, P. M., Wood, S., Jan, J. E., Applegarth, D. A., Dolman, C. L.: Progressive cerebellar ataxia, spasticity, psychomotor retardation, and hexosaminidase deficiency in a 10-year-old child: Juvenile Sandhoff disease. Neurology 27, 571–573 (1977)PubMedGoogle Scholar
  153. Max, S. R., Maclaren, N. K., Brady, R. O., Bradley, R. M., Rennels, M. B., Tanaka, J., Garcia, J. H., Cornblath, M.: GM3 (hematoside) sphingolipodystrophy. N. Engl. J. Med. 291, 929–931 (1974)PubMedGoogle Scholar
  154. Mehl, E., Jatzkewitz, H.: Eine Cerebrosidsulfatase aus Schweineniere. Hoppe Seylers Z. Physiol. Chem. 339, 260–276 (1964)PubMedGoogle Scholar
  155. Meisler, M., Rattazzi, M. C.: Immunological studies of β-galactosidase in normal human liver and GM1 gangliosidosis. Am. J. Hum. Genet. 26, 683–691 (1974)PubMedGoogle Scholar
  156. Miller, A. L., Frost, R. G., O'Brien, J. S.: Purification of human liver acid β-d-galactosidases using affinity chromatography. Analyt. Biochem. 74, 537–545 (1976)PubMedGoogle Scholar
  157. Minauf, M.: Die sogenannten amaurotischen Idiotien. Stuttgart: Fischer 1975Google Scholar
  158. Molzer, B., Bernheimer, H.: Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay. Clin. Chim. Acta 73, 163–169 (1976)CrossRefPubMedGoogle Scholar
  159. Momoi, T., Sudo, M., Tanioka, K., Nakao, Y.: Tay-Sachs disease with altered β-hexosaminidase B: new variant? Pediatr. Res. 12, 77–81 (1978)PubMedGoogle Scholar
  160. Mraz, W., Fischer, G., Jatzkewitz, H.: Low molecular weight proteins in secondary lysosomes as activators of different sphingolipid hydrolases. FEBS Lett. 67, 104–109 (1976)CrossRefPubMedGoogle Scholar
  161. Nakagawa, S., Kumin, S., Nitowsky, H. M.: Human hexosaminidase isozymes: chromatographic separation as an aid to heterozygote identification. Clin. Chim. Acta 75, 181–191 (1977)CrossRefPubMedGoogle Scholar
  162. Navon, R., Padeh, B.: Urinary test for identification of Tay-Sachs genotypes. J. Pediatr. 80, 1026–1029 (1972)PubMedGoogle Scholar
  163. Navon, R., Padeh, B., Adam, A.: Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am. J. Hum. Genet. 25, 287–293 (1973)PubMedGoogle Scholar
  164. Navon, R., Geiger, B., Ben-Yoseph, Y., Rattazzi, M. C.: Low levels of β hexosaminidase A in healthy individuals with apparent deficiency of this enzyme. Am. J. Hum. Genet. 28, 339–349 (1976)PubMedGoogle Scholar
  165. Neufeld, E. F., Lim, T. W., Shapiro, L. J.: Inherited disorders of lysosomal metabolism. Annu. Rev. Biochem. 44, 357–376 (1975)CrossRefPubMedGoogle Scholar
  166. Niermeijer, M. F., Fortuin, J. J. H., Koster, J. F., Jahodova, M., Galjaard, H.: Prenatal diagnosis of some lysosomal storage diseases. In: Enzyme therapy in lysosomal storage diseases, J. M. Tager, G. J. M. Hooghwinkel, W. T. Daems (eds.), pp. 25–33. Amsterdam: North-Holland 1974Google Scholar
  167. Norden, A. G. W., O'Brien, J. S.: Ganglioside GM1 β-galactosidase: studies in human liver and brain. Arch. Biochem. Biophys. 159, 383–392 (1973)PubMedGoogle Scholar
  168. Norden, A. G. W., O'Brien, J. S.: An electrophoretic variant of β-galactosidase with altered catalytic properties in a patient with GM1 gangliosidosis. Proc. Natl. Acad. Sci. USA 72, 240–244 (1975)PubMedGoogle Scholar
  169. Norden, A. G. W., Tennant, L. L., O'Brien, J. S.: GM1 ganglioside β-galactosidase A. Purification and studies of the enzyme from human liver. J. Biol. Chem. 249, 7969–7976 (1974)PubMedGoogle Scholar
  170. O'Brien, J. S.: Generalized gangliosidosis. J. Pediatr. 75, 167–186 (1969)PubMedGoogle Scholar
  171. O'Brien, J. S.: GM1-gangliosidosis. In: The metabolic basis of inherited disease, J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson (eds.), pp. 639–662. New York: McGraw-Hill 1972Google Scholar
  172. O'Brien, J. S.: Tay-Sachs' disease and juvenile GM2-gangliosidosis. In: Lysosomes and storage diseases, H. G. Hers, F. Van Hoof (eds.), pp. 323–344. New York-London: Academic Press 1973Google Scholar
  173. O'Brien, J. S.: Molecular genetics of GM1 β-galactosidase. Clin. Genet. 8, 303–313 (1975)PubMedGoogle Scholar
  174. O'Brien, J. S.: Ganglioside storage disease. Adv. Hum. Genet. 3, 39–98 (1977)Google Scholar
  175. O'Brien, J. S.: The gangliosidoses. In: The metabolic basis of inherited disease, J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson (eds.), pp. 841–865. New York: McGraw-Hill 1978Google Scholar
  176. O'Brien, J. S., Norden, A. G. W.: Nature of the mutation in adult β-galactosidase deficient patients. Am. J. Hum. Genet. 29, 184–190 (1977)PubMedGoogle Scholar
  177. O'Brien, J. S., Okada, S., Chen, A., Fillerup, D. L.: Tay-Sachs disease: detection of heterozygotes and homozygotes by serum hexosaminidase assay. N. Engl. J. Med. 283, 15–20 (1970)PubMedGoogle Scholar
  178. O'Brien, J. S., Okada, S., Fillerup, D. L., Veath, M. L., Adornato, B., Brenner, P. H., Leroy, J. G.: Tay-Sachs disease: prenatal diagnosis. Science 172, 61–64 (1971)PubMedGoogle Scholar
  179. O'Brien, J. S., Ho, M. W., Veath, M. L., Wilson, J. F., Myers, G., Opitz, J. M., ZuRhein, G. M., Spranger, J. W., Hartman, H. A., Haneberg, B., Grosse, F. R.: Juvenile GM1-gangliosidosis: clinical, pathological, chemical, and enzymatic studies. Clin. Genet. 3, 411–434 (1972)PubMedGoogle Scholar
  180. O'Brien, J. S., Gugler, E., Giedion, A., Wiessmann, U., Herschkowitz, N., Meier, C., Leroy, J.: Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid β-galactosidase deficiency. Clin. Genet. 9, 495–504 (1976)PubMedGoogle Scholar
  181. O'Brien, J. S., Norden, A. G. W., Miller, A. L., Frost, R. G., Kelly, T. E.: Ganglioside GM2 N-acetyl-β-d-galactosaminidase and asialo GM2 (GA2) N-acetyl-β-d-galactosaminidase; studies in human skin fibroblasts. Clin. Genet. 11, 171–183 (1977)PubMedGoogle Scholar
  182. Okada, S., O'Brien, J. S.: Tay-Sachs disease: generalized absence of a beta-d-N-acetylhexosaminidase component. Science 165, 698–700 (1969)PubMedGoogle Scholar
  183. Okada, S., Veath, M. L., O'Brien, J. S.: Juvenile GM2-gangliosidosis: partial deficiency of hexosaminidase A. J. Pediatr. 77, 1063–1065 (1970)PubMedGoogle Scholar
  184. Okada, S., McCrea, M., O'Brien, J. S.: Sandhoff's disease (GM2 gangliosidosis type 2): clinical, chemical, and enzyme studies in five patients. Pediatr. Res. 6, 606–615 (1972)PubMedGoogle Scholar
  185. O'Neill, B., Butler, A. B., Young, E., Falk, P. M., Bass, N. H.: Adult-onset GM2-gangliosidosis. Seizures, dementia, and normal pressure hydrocephalus associated with glycolipid storage in the brain and arachnoid granulation. Neurology 28, 1117–1123 (1978)PubMedGoogle Scholar
  186. Orii, T., Minami, R., Sukegawa, K., Sato, S., Tsugava, S., Horino, K., Miura, R., Nakao, T.: A new type of mucolipidosis with β-galactosidase deficiency and glycopeptiduria. Tohoku J. Exp. Med. 107, 303–315 (1972)PubMedGoogle Scholar
  187. Padeh, B., Navon, R.: Diagnosis of Tay-Sachs disease by hexosaminidase activity in leukocytes and amniotic fluid cells. Isr. J. Med. Sci. 7, 259–264 (1971)PubMedGoogle Scholar
  188. Pentchev, P. G., Barranger, J. A.: Sphingolipidoses: molecular manifestations and biochemical strategies. J. Lipid Res. 19, 401–409 (1978)PubMedGoogle Scholar
  189. Percy, A. K., Kaback, M. M., Herndon, R. M.: Metachromatic leukodystrophy: comparison of early-and late-onset forms. Neurology 27, 933–941 (1977)PubMedGoogle Scholar
  190. Philippart, M., Franklin, S. S., Gordon, A.: Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation. Ann. Intern. Med. 77, 195–200 (1972)PubMedGoogle Scholar
  191. Pierce, K. R., Kosanke, S. D., Bay, W. W., Bridges, C. H.: GM2 Gangliosidosis. Animal model: porcine cerebrospinal lipodystrophy (GM2 gangliosidosis). Am. J. Pathol. 83, 419–422 (1976)PubMedGoogle Scholar
  192. Pilz, H., Sandhoff, K., Jatzkewitz, H.: Eine Gangliosidstoffwechselstörung mit Anhäufung von Ceramidlactosid, Monosialoceramidlactosid und Tay-Sachs-Gangliosid im Gehirn. J. Neurochem. 13, 1273–1282 (1966)PubMedGoogle Scholar
  193. Pilz, H., Heipertz, R., Seidel, D.: Klinische, präklinische und pränatale Diagnose angeborener Sphingolipidosen durch Bestimmung lysosomaler Hydrolasen. Fortschr. Neurol. Psychiatr. 46, 207–221 (1978)Google Scholar
  194. Pinsky, L., Miller, J., Shanfield, B., Watters, G., Wolfe, L. S.: GM1-Gangliosidosis in skin fibroblast culture: enzymatic differences between types 1 and 2 and observations on a third variant. Am. J. Hum. Genet. 26, 563–577 (1974)PubMedGoogle Scholar
  195. Poenaru, L., Dreyfus, J. C.: Electrophoretic study of hexosaminidases. Hexosaminidase C. Clin. Chim. Acta 43, 439–442 (1973)CrossRefPubMedGoogle Scholar
  196. Poenaru, L., Weber, A., Vibert, M., Dreyfus, J. C.: Hexosaminidase C. Immunological distinction from hexosaminidase A. Biomedicine 19, 538–540 (1973)Google Scholar
  197. Potier, M., Boire, G., Dallaire, L., Melancon, S. B.: N-acetyl-β-hexosaminidase isoenzymes of amniotic fluid and maternal serum. Their relevance to prenatal diagnosis of the GM2-gangliosidoses. Clin. Chim. Acta 76, 309–315 (1977)CrossRefPubMedGoogle Scholar
  198. Price, R. G., Dance, N.: The demonstration of multiple heat stable forms of N-acetyl-β-glucosaminidase in normal human serum. Biochim. Biophys. Acta 271, 145–153 (1972)PubMedGoogle Scholar
  199. Purpura, D. P., Baker, H. J.: Neurite induction in mature cortical neurones in feline GM1-ganglioside storage disease. Nature 266, 553–554 (1976)Google Scholar
  200. Purpura, D. P., Baker, H. J.: Meganeurites and other aberrant processes of neurones in feline GM1-gangliosidosis: a Golgi study. Brain Res. 143, 13–26 (1977)CrossRefGoogle Scholar
  201. Purpura, D. P., Pappas, G. D., Baker, H. J.: Fine structure of meganeurites and secondary growth processes in feline GM1-gangliosidosis. Brain Res. 143, 1–12 (1978)CrossRefPubMedGoogle Scholar
  202. Raghavan, S., Gajewski, A., Kolodny, E. H.: GM1-ganglioside β-galactosidase in leucocytes and cultured fibroblasts. Clin. Chim. Acta 81, 47–56 (1977)CrossRefPubMedGoogle Scholar
  203. Rapin, I., Suzuki, K., Suzuki, K., Valsamis, M. P.: Adult (chronic) GM2 gangliosidosis. Arch. Neurol. 33, 120–130, (1976)PubMedGoogle Scholar
  204. Rattazzi, M. C., Brown, J. A., Davidson, R. G., Shows, T. B.: Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization. Cytogenet. Cell Genet. 14, 232–235 (1975)PubMedGoogle Scholar
  205. Rattazzi, M. C., Baker, H. A., Cork, L. C., Cox, N. R., Lanse, S. B., McCullough, R. A., Munnell, J. F.: The domestic cat as a model for human GM2 gangliosidosis: pathogenetic and therapeutic aspects. In: Models for the study of inborn errors of metabolism, F. A. Hommes (ed.). Amsterdam: Excerpta Medica (in press, 1979)Google Scholar
  206. Read, D. H., Harrington, D. D., Keenan, T. W., Hinsman, E. J.: Neuronal-visceral GM1-gangliosidosis in a dog with β-galactosidase deficiency. Science 194, 442–445 (1976)PubMedGoogle Scholar
  207. Reynolds, G. D., Baker, H. J., Reynolds, R. H.: Enzyme replacement using liposome carriers in feline GM1 gangliosidosis fibroblasts. Nature 275, 754–755 (1978)PubMedGoogle Scholar
  208. Richardson, C. L., Keenan, T. W., Morre, D. J.: Ganglioside biosynthesis. Characterization of CMP-N-acetylneuraminic acid: lactosylceramide sialyltransferase in Golgi apparatus from rat liver. Biochim. Biophys. Acta 488, 88–96 (1977)PubMedGoogle Scholar
  209. Robinson, D.: Carbohydrase deficiencies in storage diseases. Molecular Aspects of Medicine 2, 1–75 (1978)CrossRefGoogle Scholar
  210. Robinson, D., Stirling, J. L.: N-Acetyl-β-glucosaminidases in human spleen. Biochem. J. 107, 321–327 (1968)PubMedGoogle Scholar
  211. Ropers, H. H., Grzeschik, K. H., Bühler, E.: Complementation after fusion of Sandhoff and TaySachs fibroblasts. Humangenetik 26, 117–121 (1975)PubMedGoogle Scholar
  212. Rose, A. L., Pullarkat, R. K., Farmer, P. M., Mitra, N., Waran, S. P., Wisniewsky, K.: A new gangliosidosis with accumulation of GM3 ganglioside. Ann. Neurol. 2, 266–266 (1977)Google Scholar
  213. Roseman, S.: The synthesis of complex carbohydrates by multiglycosyltransferase systems and their potential function in intercellular adhesion. Chem. Phys. Lipids 5, 270–297 (1970)PubMedGoogle Scholar
  214. Rushton, A. R., Dawson, G.: Genetic linkage studies of the human glycosphingolipid β-galactosidases. Biochem. Genet. 15, 1071–1082 (1977)PubMedGoogle Scholar
  215. Saifer, A., Parkhurst, G. W., Amoroso, J.: Automated differentiation and measurement of hexosaminidase isoenzymes in biological fluids and its application to pre-and postnatal detection of Tay-Sachs disease. Clin. Chem. 21, 334–342 (1975)PubMedGoogle Scholar
  216. Saifer, A., Amoroso, J., Perle, G.: Urinary hexosaminidase analysis for the identification of Tay-Sachs genotypes. Clin. Chim. Acta 67, 315–319 (1976)CrossRefPubMedGoogle Scholar
  217. Sandhoff, K.: Auftrennung der Säuger-N-Acetyl-β-d-hexosaminidase in multiple Formen durch Elektrofokussierung. Hoppe Seylers Z. Physiol. Chem. 349, 1095–1098 (1968)PubMedGoogle Scholar
  218. Sandhoff, K.: Variation of β-N-acetylhexosaminidase-pattern in Tay-Sachs disease. FEBS Lett. 4, 351–354 (1969)CrossRefPubMedGoogle Scholar
  219. Sandhoff, K.: Multiple human hexosaminidases. Birth Defects 9, 214–222 (1973)PubMedGoogle Scholar
  220. Sandhoff, K.: The biochemistry of sphingolipid storage diseases. Angew. Chem. [Engl.] 16, 273–285 (1977)Google Scholar
  221. Sandhoff, K., Harzer, K.: Total hexosaminidase deficiency in Tay-Sachs' disease (variant 0). In: Lysosomes and storage diseases, H. G. Hers, F. Van Hoof (eds.) pp. 345–356. New York: Academic Press (1973)Google Scholar
  222. Sandhoff, K., Wässle, W.: Anreicherung und Charakterisierung zweier Formen der menschlichen N-Acetyl-β-d-hexosaminidase. Hoppe Seylers Z. Physiol. Chem. 352, 1119–1133 (1971)PubMedGoogle Scholar
  223. Sandhoff, K., Andreae, U., Jatzkewitz, H.: Deficient hexosaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Pathol. Eur. 3, 278–285 (1968)PubMedGoogle Scholar
  224. Sandhoff, K., Harzer, K., Wässle, W., Jatzkewitz, H.: Enzyme alterations in lipid storage in three variants of Tay-Sachs disease. J. Neurochem. 18, 2469–2489 (1971)PubMedGoogle Scholar
  225. Sandhoff, K., Conzelmann, E., Nehrkorn, H.: Specificity of human liver hexosaminidases A and B against glycosphingolipids GM2 and GA2. Purification of the enzymes by affinity chromatography employing specific elution. Hoppe Seylers Z. Physiol. Chem. 358, 779–787 (1977)PubMedGoogle Scholar
  226. Schettler, G., Kahlke, W.: Gangliosidoses. In: Lipids and lipidoses, G. Schettler (ed.), pp. 213–259. Berlin-Heidelberg-New York: Springer 1967Google Scholar
  227. Schneck, L., Friedland, J., Valenti, C., Adachi, M., Amsterdam, D., Volk, B. W.: Prenatal diagnosis of Tay-Sachs disease. Lancet 1970I, 582–583Google Scholar
  228. Schneck, L., Adachi, M., Volk, B. W.: The fetal aspects of Tay-Sachs disease. Pediatrics 49, 342–351 (1972)PubMedGoogle Scholar
  229. Schneck, L., Pinkett, B., Volk, B. W.: Asialo GM2-ganglioside in brain fetal Tay-Sachs disease. J. Neurochem. 24, 183–184 (1975)PubMedGoogle Scholar
  230. Schram, A. W., Hamers, M. N., Samson, M. R., Cordus, S., de Jong, A., Brown, I., Robinson, D., Tager, J. M.: Factors affecting the hydrolysis of ceramide-3 by α-galactosidase A from human liver. Biochim. Biophys. Acta (in press, 1979)Google Scholar
  231. Snyder, P. D. Jr., Wold, F., Bernlohr, R. W., Dullum, C., Desnick, R. J., Krivit, W., Condre, R. M.: Enzyme therapy. II. Purified human α-galactosidase A. Stabilization to heat and protease degradation by complexing with antibody and by chemical modification. Biochim. Biophys. Acta 350, 432–436 (1974)PubMedGoogle Scholar
  232. Spence, M. W., Ripley, B. A., Embil, J. A., Tibbles, A. R.: A new variant of Sandhoff's disease. Pediatr. Res. 8, 628–637 (1974)PubMedGoogle Scholar
  233. Spence, M. W., Welch, J. P., Burgen, J. K., MacKinnon, K. E., MacDonald, J. M., Clarke, J. T. R.: Studies of hexosaminidase activity in a normal adult male with absent serum hex A. Clin. Res. 25A, 692–692 (1977)Google Scholar
  234. Srivastava, S. K., Ansari, N. H.: Altered α subunits in Tay-Sachs disease. Nature 273, 245–246 (1978)PubMedGoogle Scholar
  235. Srivastava, S. K., Beutler, E.: Hexosaminidase A and hexosaminidase B: studies in Tay-Sachs' and Sandhoff's disease. Nature 241, 463–463 (1973)Google Scholar
  236. Srivastava, S. K., Beutler, E.: Studies on human β-d-N-acetylhexosaminidases. III. Biochemical genetics of Tay-Sachs and Sandhoff's diseases. J. Biol. Chem. 249, 2054–2057 (1974)PubMedGoogle Scholar
  237. Srivastava, S. K., Awasthi, Y. C., Yoshida, A., Beutler, E.: Studies on human β-d-N-acetylhexosaminidases. I. Purification and properties. J. Biol. Chem. 249, 2043–2048 (1974)PubMedGoogle Scholar
  238. Stahl, P., Six, H., Rodman, J. S., Schlesinger, P., Tulsiani, D. R. P., Touster, O.: Evidence for specific recognition sites mediating clearance of lysosomal enzymes in vivo. Proc. Natl. Acad. Sci. USA 73, 4045–4049 (1976)PubMedGoogle Scholar
  239. Stevenson, R. E., Taylor, H. A., Jr., Parks, S. E.: β-galactosidase deficiency: prolonged survival in three patients following early central nervous system deterioration. Clin. Genet. 13, 305–313 (1978)PubMedGoogle Scholar
  240. Stirling, J. L.: A new form of N-acetyl-β-glucosaminidase present in pregnancy serum. Biochem. J. 123, 11P (1971)Google Scholar
  241. Stirling, J. L.: Separation and characterization of N-acetyl-β-glucosaminidases A and P from maternal serum. Biochim. Biophys. Acta 271, 154–162 (1972)PubMedGoogle Scholar
  242. Strecker, G., Herlant-Peers, M. C., Fournet, B., Montreuil, J.: Structure of seven oligosaccharides excreted in the urine of a patient with Sandhoff's disease (GM2-gangliosidosisvariant 0). Eur. J. Biochem. 81, 165–171 (1977)PubMedGoogle Scholar
  243. Suzuki, K., Suzuki, Y.: Globoid cell leukodystrophy (Krabbe's disease): deficiency of galactocerebroside β-galactosidase. Proc. Natl. Acad. Sci. USA 66, 302–309 (1970)PubMedGoogle Scholar
  244. Suzuki, K., Suzuki, K., Rapin, I., Suzuki, Y., Ishii, N.: Juvenile GM2-gangliosidosis. Clinical variant of Tay-Sachs disease or a new disease. Neurology 20, 190–204 (1970)PubMedGoogle Scholar
  245. Suzuki, Y., Suzuki, K.: Partial deficiency of hexosaminidase component A in juvenile GM2-gangliosidosis. Neurology 20, 848–851 (1970)PubMedGoogle Scholar
  246. Suzuki, Y., Suzuki, K.: Glycosphingolipid β-galactosidases. II. Electrofocusing characterization of the enzymes in human globoid cell leukodystrophy (Krabbe's disease). J. Biol. Chem. 249, 2105–2108 (1974a)PubMedGoogle Scholar
  247. Suzuki, Y., Suzuki, K.: Glycosphingolipid β-galactosidases. IV. Electrofocusing characterization in GM1 gangliosidosis. J. Biol. Chem. 249, 2113–2117 (1974b)PubMedGoogle Scholar
  248. Suzuki, Y., Koizumi, Y., Togari, H., Ogawa, Y.: Sandhoff disease: diagnosis of heterozygous carriers by serum hexosaminidase assay. Clin. Chim. Acta 48, 153–158 (1973)CrossRefPubMedGoogle Scholar
  249. Suzuki, Y., Nakamura, N., Fukuoka, K., Shimada, Y., Masanori, U.: β-Galactosidase deficiency in juvenile and adult patients. Report of six Japanese cases and review of literature. Hum. Genet. 36, 219–229 (1977)PubMedGoogle Scholar
  250. Suzuki, Y., Nakamura, N., Fukuoka, K.: GM1-Gangliosidoses: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types. Hum. Genet. 43, 127–131 (1978)PubMedGoogle Scholar
  251. Svennerholm, L.: The chemical structure of normal human brain and Tay-Sachs ganglioside. Biochem. Biophys. Res. Commun. 9, 436–441 (1962)PubMedGoogle Scholar
  252. Svennerholm, L.: Molecular neuropathology. Prog. Brain Res. 45, 101–122 (1976a)PubMedGoogle Scholar
  253. Svennerholm, L.: Prenatal diagnosis of neurolipidoses. In: Prenatal diagnosis, A. Boué (ed.), pp. 141–153: Paris: Insern 1976bGoogle Scholar
  254. Svennerholm, L.: Biochemical techniques for prenatal diagnosis of inherited metabolic diseases. (in press, 1979)Google Scholar
  255. Tallman, J. F., Brady, R. O., Navon, R., Padeh, B.: Ganglioside catabolism in hexosaminidase A-deficient adults. Nature 252, 254–255 (1974a)PubMedGoogle Scholar
  256. Tallman, J. F., Brady, R. O., Quirk, J. M., Villalba, M., Gal, A. E.: Isolation and relationship of human hexosaminidases. J. Biol. Chem. 249, 3489–3499 (1974b)PubMedGoogle Scholar
  257. Tallman, J. F., Pentchev, P. G., Brady, R. O.: An enzymological approach to the lipidoses. Enzyme 18, 136–149 (1974c)PubMedGoogle Scholar
  258. Tanaka, H., Suzuki, K.: Lactosylceramide β-galactosidase in human sphingolipidoses. Evidence for two genetically distinct enzymes. J. Biol. Chem. 250, 2324–2332 (1975)PubMedGoogle Scholar
  259. Tanaka, J., Garcia, J. H., Max, S. R., Viloria, J. E., Kamijyo, Y., McLaren, N. K., Cornblath, M., Brady, R. O.: Cerebral sponginess and GM3 gangliosidosis: ultrastructure and probable pathogenesis. J. Neuropathol. Exp. Neurol. 34, 249–262 (1975)PubMedGoogle Scholar
  260. Tay, W. A.: Symmetrical changes in the region of the yellow spot in each eye of an infant. Trans. Ophthalmol. Soc. UK 1, 55–57 (1881)Google Scholar
  261. Terry, R. D., Weiss, M.: Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum. J. Neuropathol. Exp. Neurol. 22, 18–55 (1963)PubMedGoogle Scholar
  262. Thomas, G. H.: β-d-Galactosidase in human urine, deficiency in generalized gangliosidosis. J. Lab. Clin. Med. 74, 725–731 (1969)PubMedGoogle Scholar
  263. Thomas, G. H., Taylor, H. A., Miller, C. S., Axelman, J.: Migeon, B. R.: Genetic complementation after fusion of Tay-Sachs and Sandhoff cells. Nature 250, 580–582 (1974)PubMedGoogle Scholar
  264. Thompson, J. N., Stoolmiller, A. C., Matalon, R., Dorfman, A.: N-Acetyl-β-hexosaminidase: role in the degradation of glycosaminoglycans. Science 181, 866–867 (1973)PubMedGoogle Scholar
  265. Tomasi, L. G., Fukushima, D. K., Kolodny, E. H.: Steroid hexosaminidase activity in Tay-Sachs and Sandhoff-Jatzkewitz diseases. Neurology 24, 1158–1165 (1974)PubMedGoogle Scholar
  266. Tsay, G. C., Dawson, G.: Oligosaccharide storage in brains from patients with fucosidosis, GM1-gangliosidosis and GM2-gangliosidosis (Sandhoff's disease). J. Neurochem. 27, 733–740 (1976)PubMedGoogle Scholar
  267. Tsay, G. C., Dawson, G., Li, Y. T.: Structure of the glycopeptide storage material in GM1-gangliosidosis. Biochim. Biophys. Acta 385, 305–311 (1975)PubMedGoogle Scholar
  268. Tsuboyama, A., Miki, F., Yoshida, M., Ogura, Y., Miyatake, T.: The use of tears for diagnosis of GM1 gangliosidosis. Clin. Chim. Acta 80, 237–242 (1977)CrossRefPubMedGoogle Scholar
  269. Ullrich, K., Mersman, G., Weber, E., Figura, K. von: Evidence for lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem. J. 170, 643–650 (1978)PubMedGoogle Scholar
  270. Vidgoff, J., Buist, N. R. M., O'Brien, J. S.: Absence of β-N-acetyl-d-hexosaminidase A activity in a healthy woman. Am. J. Hum. Genet. 25, 372–381 (1973)PubMedGoogle Scholar
  271. Volk, B. W., Schneck, L.: The gangliosidosis. New York-London: Plenum Press 1975Google Scholar
  272. Volk, B. W., Schneck, L.: Current trends in sphingolipidoses and allied disorders. New York-London: Plenum Press 1976Google Scholar
  273. Wenger, D. A., Goodman, S. I., Myers, G. G.: Beta-galactosidase deficiency in young adults. Lancet 1974II, 1319–1320 (1974a)Google Scholar
  274. Wenger, D. A., Sattler, M., Hiatt, W.: Globoid cell leukodystrophy: deficiency of lactosyl ceramide beta-galactosidase. Proc. Natl. Acad. Sci. USA 71, 854–857 (1974b)PubMedGoogle Scholar
  275. Wenger, D. A., Tarby, T. J., Wharton, C.: Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and β-galactosidase deficiencies. Biochem. Biophys. Res. Commun. 82, 589–595 (1978)PubMedGoogle Scholar
  276. Werries, E., Neue, J., Buddecke, E.: Evidence for different glycohydrolase and glycosyltransferase activities of β-N-acetyl-hexosaminidases A and B. Hoppe Seylers Z. Physiol. Chem. 356, 953–960 (1975)PubMedGoogle Scholar
  277. Witt, J. de, Hoeksema, H. L., Halley, D., Hagemeijer, A., Bootsma, D., Westerveld, A.: Regional localization of a β-galactosidase locus on human chromosome 22. Somatic Cell Genetics 3, 351–363 (1977)PubMedGoogle Scholar
  278. Wit-Verbeek, H. A. de, Hoogeveen, A., Galjaard, H.: Complementation studies with enucleated fibroblasts from different variants of β-galactosidase deficiency. Exp. Cell Res. 113, 215–218 (1978)PubMedGoogle Scholar
  279. Wolfe, L. S., Senior, R. G., Ng Ying Kin, N. M. K.: The structures of oligosaccharides accumulating in the liver of GM1-gangliosidosis, type I. J. Biol. Chem. 249, 1828–1838 (1974)PubMedGoogle Scholar
  280. Wood, S.: Juvenile Sandhoff disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion. Hum. Genet. 41, 325–329 (1978)CrossRefPubMedGoogle Scholar
  281. Wood, S., MacDougall, B. G.: Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts. Am. J. Hum. Genet. 28, 489–495 (1976)PubMedGoogle Scholar
  282. Wyatt, P. R., Cox, D. M., Hoogstraten, J.: Tay-Sachs disease: ultrastructural studies on cultured fibroblasts. Pediatr. Res. 12, 310–313 (1978)PubMedGoogle Scholar
  283. Yamakawa, T., Nagai, Y.: Glycolipids at the cell surface and their biological functions. Trends in Biological Sciences 3, 128–131 (1978)Google Scholar
  284. Yamamoto, A., Adachi, S., Kawamura, S., Takahashi, M., Kitani, T., Ohtori, T., Shinji, Y., Nishikawa, M.: Localized β-galactosidase deficiency. Arch. Intern. Med. 134, 627–634 (1974)CrossRefPubMedGoogle Scholar
  285. Young, E. P., Ellis, R. B., Patrick, A. D.: Leucocyte β-galactosidase activity in GM1-gangliosidosis. Pediatrics 50, 502–509 (1972)PubMedGoogle Scholar
  286. Zeman, W., Siakotos, A. N.: The neuronal ceroid-lipofuscinoses. In: Lysosomes and storage diseases, H. G. Hers, F. Van Hoff (eds.), pp. 519–551. New York: Academic Press 1973Google Scholar
  287. Zerfowski, J., Sandhoff, K.: Juvenile GM2-Gangliosidose mit veränderter Substratspezifität der Hexosaminidase A. Acta Neuropathol. (Berl.) 27, 225–232 (1974)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • K. Sandhoff
    • 1
  • Helene Christomanou
    • 1
  1. 1.Max-Planck-Institut für PsychiatrieNeurochemische AbteilungMünchen 40Federal German Republic

Personalised recommendations